A Phase I/II Study of Pomalidomide, Dexamethasone and Ixazomib vs. Pomalidomide and Dexamethasone for Patients With Multiple Myeloma Refractory to Lenalidomide and Proteasome Inhibitor-Based Therapy
Phase of Trial: Phase I/II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Ixazomib (Primary) ; Pomalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms Alliance
- 20 Jun 2017 Status changed from recruiting to suspended because DSMB recommendation to revise study design
- 04 Oct 2016 Planned primary completion date changed from 1 Aug 2019 to 1 Dec 2017.
- 02 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2019.